Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DISHMAN PHARMA PFIZER/
DISHMAN PHARMA
 
P/E (TTM) x 38.2 30.0 127.4% View Chart
P/BV x 6.0 3.3 178.7% View Chart
Dividend Yield % 1.7 0.7 251.3%  

Financials

 PFIZER   DISHMAN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-23
DISHMAN PHARMA
Mar-16
PFIZER/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs4,662374 1,245.3%   
Low Rs3,407129 2,643.1%   
Sales per share (Unadj.) Rs530.0197.0 269.0%  
Earnings per share (Unadj.) Rs136.421.2 643.6%  
Cash flow per share (Unadj.) Rs159.434.7 459.4%  
Dividends per share (Unadj.) Rs70.002.00 3,500.0%  
Avg Dividend yield %1.70.8 218.3%  
Book value per share (Unadj.) Rs701.0179.9 389.8%  
Shares outstanding (eoy) m45.7580.70 56.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.3 595.9%   
Avg P/E ratio x29.611.9 249.1%  
P/CF ratio (eoy) x25.37.3 349.0%  
Price / Book Value ratio x5.81.4 411.4%  
Dividend payout %51.39.4 543.8%   
Avg Mkt Cap Rs m184,57620,307 908.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,3175,355 61.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,24815,898 152.5%  
Other income Rs m1,011265 380.7%   
Total revenues Rs m25,25816,163 156.3%   
Gross profit Rs m8,4204,103 205.2%  
Depreciation Rs m1,0551,091 96.7%   
Interest Rs m135944 14.3%   
Profit before tax Rs m8,2402,334 353.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,001624 320.8%   
Profit after tax Rs m6,2391,710 364.9%  
Gross profit margin %34.725.8 134.5%  
Effective tax rate %24.326.7 90.9%   
Net profit margin %25.710.8 239.2%  
BALANCE SHEET DATA
Current assets Rs m24,93311,018 226.3%   
Current liabilities Rs m6,5749,517 69.1%   
Net working cap to sales %75.79.4 802.0%  
Current ratio x3.81.2 327.6%  
Inventory Days Days9357 163.9%  
Debtors Days Days23 65.3%  
Net fixed assets Rs m13,78018,787 73.3%   
Share capital Rs m458161 283.5%   
"Free" reserves Rs m31,61614,354 220.3%   
Net worth Rs m32,07314,516 221.0%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m39,03129,805 131.0%  
Interest coverage x62.13.5 1,789.9%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.5 116.5%   
Return on assets %16.38.9 183.4%  
Return on equity %19.511.8 165.1%  
Return on capital %26.117.5 149.0%  
Exports to sales %2.824.9 11.4%   
Imports to sales %03.7 0.9%   
Exports (fob) Rs m6883,956 17.4%   
Imports (cif) Rs m8594 1.4%   
Fx inflow Rs m6884,952 13.9%   
Fx outflow Rs m8697 1.2%   
Net fx Rs m6794,255 16.0%   
CASH FLOW
From Operations Rs m3,5572,786 127.6%  
From Investments Rs m-361-1,529 23.6%  
From Financial Activity Rs m-3,458-941 367.5%  
Net Cashflow Rs m-262317 -82.7%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 18.2 23.0 79.2%  
FIIs % 3.0 12.0 25.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 38.6 93.5%  
Shareholders   112,456 52,291 215.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs Dishman Pharma Share Price Performance

Period Pfizer Dishman Pharma S&P BSE HEALTHCARE
1-Day -4.80% 2.87% 1.18%
1-Month -8.24% -2.45% -0.75%
1-Year 21.78% 96.38% 61.82%
3-Year CAGR -2.07% 89.34% 18.16%
5-Year CAGR 4.95% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Pfizer, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.